SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001437749-21-007035
Filing Date
2021-03-24
Accepted
2021-03-24 16:31:10
Documents
33
Period of Report
2020-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K/A rvph20201231_10ka.htm 10-K/A 311631
2 EXHIBIT 31.1 ex_236168.htm EX-31.1 5611
3 EXHIBIT 31.2 ex_236169.htm EX-31.2 5618
4 g2.jpg GRAPHIC 7352
5 g3.jpg GRAPHIC 9684
6 g4.jpg GRAPHIC 7969
7 g5.jpg GRAPHIC 8657
8 g7.jpg GRAPHIC 18245
9 g8.jpg GRAPHIC 18163
10 g9.jpg GRAPHIC 18053
11 g10.jpg GRAPHIC 18491
12 g11.jpg GRAPHIC 8248
13 g12.jpg GRAPHIC 6794
14 g13.jpg GRAPHIC 11682
15 g14.jpg GRAPHIC 7094
16 g15.jpg GRAPHIC 13936
17 g16.jpg GRAPHIC 21918
18 g17.jpg GRAPHIC 11876
19 g18.jpg GRAPHIC 10955
20 g19.jpg GRAPHIC 17182
21 g20.jpg GRAPHIC 9747
22 g21.jpg GRAPHIC 8407
23 g22.jpg GRAPHIC 10252
24 g23.jpg GRAPHIC 7743
25 g24.jpg GRAPHIC 10536
26 g25.jpg GRAPHIC 8295
27 g26.jpg GRAPHIC 9591
28 g27.jpg GRAPHIC 9330
29 image1.jpg GRAPHIC 48739
30 image2.jpg GRAPHIC 62750
31 image14.jpg GRAPHIC 14770
32 image15.jpg GRAPHIC 17141
33 image16.jpg GRAPHIC 9862
  Complete submission text file 0001437749-21-007035.txt   937855
Mailing Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014
Business Address 19925 STEVENS CREEK BLVD. SUITE 100 CUPERTINO CA 95014 2127105220
REVIVA PHARMACEUTICALS HOLDINGS, INC. (Filer) CIK: 0001742927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-38634 | Film No.: 21768539
SIC: 2834 Pharmaceutical Preparations